Clinical Trial Update: Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia [NA]

View source ↗

Summary

A completed non-inferiority trial comparing cloxacillin to cefazolin for methicillin-susceptible Staphylococcus aureus bacteremia has been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)
• cloxacillin (cloxacillin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus | NA | Status: COMPLETED